BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• Business

  Illumina to Announce First Quarter 2018 Financial Results on Tuesday, April 24, 2018

  Illumina, Inc. announced that it will issue results for first quarter 2018 following the close of market on Tuesday, April 24, 2018.

  April 10, 2018

   · 

  1 min read
• Pharm Country

  LSNE Announces Expansion Of Its Current Capabilities And QC Laboratory Space

  New Hampshire-based Contract Development and Manufacturing Organization (CDMO) will build new state-of-the-art laboratory to support its growing pharmaceutical and medical device client base

  April 10, 2018

   · 

  2 min read
• BioForest

  Frazier Healthcare Partners Closes Oversubscribed $780 Million Growth Buyout Fund

  Frazier Healthcare Partners, a leading healthcare-focused investment firm founded in 1991, today announced the closing of Frazier Healthcare Growth Buyout Fund IX, L.P. with $780 million in committed capital.

  April 10, 2018

   · 

  2 min read
• Pharm Country

  Applied DNA to Debut Security Print Platform Solution Featuring Videojet 1860M CIJ Printer at INTERPHEX 2018

  Applied DNA Sciences, Inc.will debut its security print platform solution featuring the Videojet 1860M continuous inkjet (CIJ) printer at INTERPHEX 2018 in Booth 3957 at the Jacob K. Javits Convention Center in New York City on April 17-19.

  April 10, 2018

   · 

  5 min read
• Bio NC

  SonaCare Medical Sponsors the Inaugural Focal Therapy Masterclass at Imperial College London

  Over 120 urologists gather at Imperial College London to learn new diagnostic techniques and minimally invasive focal approaches for treating prostate cancer.

  April 10, 2018

   · 

  2 min read
• Genetown

  CROMSOURCE Offers Clients One Trial One Price™ Guarantee

  CROMSOURCE announced a service offering and guarantee for their clients - One Trial One Price[TM].

  April 10, 2018

   · 

  2 min read
• Pharm Country

  MYOS RENS Technology Introduces New Sports Nutrition Product Line, Yolked™, and Earns Prestigious “Certified For Sport®" Certification From NSF International

  NSF “Certified for Sport®" Certification Further Demonstrates MYOS’ Commitment To Providing Safe, Quality Products

  April 10, 2018

   · 

  3 min read
• Business

  Former CoLucid CEO Thomas P. Mathers joins Pappas Capital as Partner

  Pappas Capital announced that Thomas P. “Tom” Mathers has joined the firm as a partner. Mathers previously served as CEO of CoLucid Pharmaceuticals.

  April 10, 2018

   · 

  2 min read
• Business

  Illumina and Loxo Oncology to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics

  Expands Illumina’s oncology offerings for NextSeq™ 550Dx with a companion diagnostic version of TruSight™ Tumor 170 for solid tumors

  April 10, 2018

   · 

  9 min read
• Drug Development

  Abide Therapeutics Presents Positive Data from a Phase 1b Study of ABX-1431 in Tourette Syndrome at the American Academy of Neurology 70th Annual Meeting

  ABX-1431 Study Data Featured in AAN Emerging Science Session Data Blitz Single Oral Doses of ABX-1431 Demonstrate Statistically Significant Activity in Tourette Syndrome

  April 10, 2018

   · 

  3 min read